BIGG

COVID-19 rapid guideline: dermatological conditions treated with drugs affecting the immune response

Ano de publicação: 2020

The purpose of this guideline is to maximise the safety of children and adults who have dermatological conditions treated with drugs affecting the immune response during the COVID-19 pandemic. It also aims to protect staff from infection and enable services to make the best use of NHS resources.